Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysis.
Rubino M, Di Stasio GD, Bodei L, Papi S, Rocca PA, Ferrari ME, Fodor CI, Bagnardi V, Frassoni S, Mei R, Fazio N, Ceci F, Grana CM. Rubino M, et al. Among authors: ceci f. Endocrine. 2024 May;84(2):704-710. doi: 10.1007/s12020-024-03707-5. Epub 2024 Feb 7. Endocrine. 2024. PMID: 38324106
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models.
Marvaso G, Isaksson LJ, Zaffaroni M, Vincini MG, Summers PE, Pepa M, Corrao G, Mazzola GC, Rotondi M, Mastroleo F, Raimondi S, Alessi S, Pricolo P, Luzzago S, Mistretta FA, Ferro M, Cattani F, Ceci F, Musi G, De Cobelli O, Cremonesi M, Gandini S, La Torre D, Orecchia R, Petralia G, Jereczek-Fossa BA. Marvaso G, et al. Among authors: ceci f. Eur Radiol. 2024 Mar 20. doi: 10.1007/s00330-024-10699-3. Online ahead of print. Eur Radiol. 2024. PMID: 38507053
A PET-Surrogate Signature for the Interrogation of the Metabolic Status of Breast Cancers.
Confalonieri S, Matoskova B, Pennisi R, Martino F, De Mario A, Miloro G, Montani F, Rotta L, Ferrari ME, Gilardi L, Ceci F, Grana CM, Rizzuto R, Mammucari C, Di Fiore PP, Lanzetti L. Confalonieri S, et al. Among authors: ceci f. Adv Sci (Weinh). 2024 May 17:e2308255. doi: 10.1002/advs.202308255. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 38757578
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study.
Rajwa P, Robesti D, Chaloupka M, Zattoni F, Giesen A, Huebner NA, Krzywon A, Miszczyk M, Moll M, Stando R, Cisero E, Semko S, Checcucci E, Devos G, Apfelbeck M, Gatti C, Marra G, van den Bergh RCN, Goldner G, Rasul S, Ceci F, Dal Moro F, Porpiglia F, Gontero P, Bjartell A, Stief C, Heidenreich A, Joniau S, Briganti A, Shariat SF, Gandaglia G; EAU-Young Academic Urologists (YAU) Prostate Cancer Working Party. Rajwa P, et al. Among authors: ceci f. Eur Urol Oncol. 2023 Oct 14:S2588-9311(23)00197-9. doi: 10.1016/j.euo.2023.09.006. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37845121 Free article.
How to Report PSMA PET.
Swiha M, Ayati N, Oprea-Lager DE, Ceci F, Emmett L. Swiha M, et al. Among authors: ceci f. Semin Nucl Med. 2024 Jan;54(1):14-29. doi: 10.1053/j.semnuclmed.2023.07.007. Epub 2023 Aug 8. Semin Nucl Med. 2024. PMID: 37558507 Review.
Extreme-hypofractionated RT with concomitant boost to the DIL in PCa: a 5-year update on oncological and patient-reported outcomes for the phase II trial "GIVE ME FIVE".
Marvaso G, Corrao G, Repetti I, Lorubbio C, Bellerba F, Zaffaroni M, Vincini MG, Zerini D, Alessi S, Luzzago S, Mistretta FA, Fodor C, Cambria R, Cattani F, Ceci F, Musi G, De Cobelli O, Zilli T, Gandini S, Orecchia R, Petralia G, Jereczek-Fossa BA. Marvaso G, et al. Among authors: ceci f. World J Urol. 2024 Mar 16;42(1):169. doi: 10.1007/s00345-024-04876-8. World J Urol. 2024. PMID: 38492078
264 results